The POEMS syndrome is a multisystemic syndrome associated with plasma cell
dyscrasia, characterized by the combination of polyneuropathy, organomegaly
, endocrinopathy, M protein, and skin changes, Renal involvement in POEMS s
yndrome is rare (26 reported cases), It has been described as membranoproli
ferative glomerulonephritis-like lesions (MPGN-like), mesangiolytic glomeru
lonephritis, or thrombotic microangiopathy, Proinflammatory cytokines (TNF-
alpha, IL-1, IL-6) have been implicated in the physiopathogenesis of POEMS
syndrome, particularly when there is renal involvement. Growth factors (FGF
-beta, TGF-beta, PDGF) have been implicated in renal lesions of the same hi
stological type but of different origins, An increase in serum vascular end
othelial growth factor (VEGF) has been reported in POEMS syndrome (20 of 22
cases), Circulating levels of these factors were determined in 4 patients
with POEMS and renal involvement (3 MPGN-like, 1 MPGN-like, and mesangiolys
is) and compared with those obtained in 4 patients with POEMS without clini
cal renal involvement and in 4 patients with primitive membranoproliferativ
e glomerulonephritis (MPGN), TNF-alpha, IL-1 beta, and IL-6 were determined
with an immunoradiometric assay, and VEGF, PDGF, FGF-beta, and TGF-beta wi
th an enzyme-linked immunosorbent assay. Among the patients with POEMS synd
rome, there was no difference in proinflammatory cytokines and growth facto
rs between those with or without renal involvement. VEGF is the only growth
factor that differentiates MPGN in POEMS syndrome from primitive MPGN. (C)
1999 by the National Kidney Foundation, Inc.